Latest On Aleafia Health Inc (ALEAF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-25 17:00 EST | News | Aleafia sets out to explore strategic alternatives while debt default looms | N/A |  |
| 2023-02-13 16:03 EST | News | Aleafia Health Inc. (ALEAF) Q3 2023 Earnings Call Transcript | N/A | |
| 2022-11-10 11:45 EST | News | Aleafia Health Inc. 2023 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-11-10 11:45 EST | News | Aleafia Health Inc. (ALEAF) Q2 2023 Earnings Call Transcript | N/A | |
| 2022-09-16 22:06 EST | News | Aleafia Health announces TSX decision to extend delisting review | N/A | |
| 2022-08-11 21:50 EST | News | Aleafia Health Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-08-11 21:50 EST | News | Aleafia Health Inc. (ALEAF) CEO Tricia Symmes on Q1 2023 Results - Earnings Call Transcript | N/A | |
| 2022-07-05 08:21 EST | News | Aleafia Health Inc.'s (ALEAF) CEO Tricia Symmes on Q5 2022 Results - Earnings Call Transcript | N/A | |
| 2022-06-28 17:31 EST | News | Aleafia Health reports Q5 results | N/A | |
| 2022-06-28 17:31 EST | News | Aleafia Health Inc. (ALEAF) CEO Tricia Symmes on Q5 2022 Results - Earnings Call Transcript | N/A | |
| 2022-06-28 17:31 EST | News | Aleafia Health stock surges 22% on rise in cannabis revenue | N/A | |
| 2022-06-24 20:29 EST | News | Aleafia Health closes ~$5.6M private placement | N/A | |
| 2022-03-29 19:05 EST | News | Aleafia Health provides update on its convertible debt maturing June 27, 2022 | N/A | |
| 2022-03-25 11:24 EST | News | Aleafia Health gains market share in adult use cannabis market, provides strong sales outlook | N/A | |
| 2022-02-15 17:14 EST | News | Aleafia Health, Inc. (ALEAF) CEO Tricia Symmes on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-11 19:58 EST | News | Aleafia Health, Inc. (ALEAF) CEO Geoffrey Benic on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-13 07:28 EST | News | Aleafia Health, Inc. (ALEAF) CEO Geoffrey Benic on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-12 10:50 EST | News | Aleafia Health reports Q2 results | N/A | |
| 2021-07-29 12:16 EST | News | Aleafia Health names Mark Sandler as board chair | N/A | |
| 2021-07-22 17:17 EST | News | Aleafia Health picks veteran finance professional as CFO | N/A | |
| 2021-03-26 03:31 EST | News | Aleafia Health Inc. (ALEAF) CEO Geoffrey Benic on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-25 08:00 EST | News | Aleafia Health reports Q4 results | N/A | |
| 2021-02-23 08:43 EST | News | Aleafia Health: Slow Start, But 2021 Could Prove Pivotal | N/A | |
| 2021-02-17 15:45 EST | News | Aleafia Health increases bought deal offering to $20M | N/A | |
| 2021-01-08 12:59 EST | News | Aleafia Health announces supply agreement with Apipharm | N/A | |
| 2021-01-05 10:46 EST | News | Aleafia Health to repay $25M convertible debenture with cash | N/A | |
| 2020-12-16 00:47 EST | News | Aleafia Health inks supply pact with Robes Cannabis | N/A | |
| 2020-12-07 20:02 EST | News | Aleafia Health: Significantly Undervalued And About To Make A Profit | N/A | |
| 2020-12-04 20:49 EST | News | Aleafia Health launches CBD 50 cannabis oil | N/A | |
| 2020-12-04 06:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 00:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-13 15:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 15:08 EST | News | Aleafia Health trades in red on Q3 widening loss | N/A | |
| 2020-11-12 15:08 EST | News | Aleafia Health Inc. (ALEAF) CEO Geoffrey Benic on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-11 09:57 EST | News | Aleafia Health reports Q3 results | N/A | |
| 2020-10-08 21:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-29 20:16 EST | News | Aleafia Health launches Cannabis 2.0 portfolio with 510 vape cartridges | N/A | |
| 2020-09-26 16:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-02 05:28 EST | News | Aleafia Health Subsidiary receives regulatory approvals for cannabis sales in Germany | N/A | |
| 2020-08-14 12:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 07:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-13 09:17 EST | News | Aleafia Health -5% despite Q2 revenue beat | N/A | |
| 2020-08-13 09:17 EST | News | Aleafia Health's (ALEAF) CEO Geoffrey Benic on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-12 07:36 EST | News | Aleafia Health beats on revenue | N/A | |
| 2020-08-06 16:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:39 EST | Financials | Company financials have been released. | Neutral | |
About Aleafia Health Inc (ALEAF):
Aleafia Health Inc. operates as an integrated cannabis health and wellness company. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil drops and capsules, and oral sprays. The company offers its products under the Emblem and Symbl brands. It also operates a network of 25 medical cannabis clinics; and education centers. Aleafia Health Inc. is headquartered in Concord, Canada.
General
- Name Aleafia Health Inc
- Symbol ALEAF
- Type Common Stock
- Exchange OTCQX
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 173
- Fiscal Year EndDecember
- Web URLhttp://www.aleafiahealth.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 5.29
- Price/Book (Most Recent Quarter) 0.61
- Enterprise Value Revenue 5.52
- Enterprise Value EBITDA 34.85
View More
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin -112%
- Return on Assets -4%
- Return on Equity -10%
- Revenue Per Share $0
- Gross Profit 20.78 million
- Quarterly Earnings Growth 0.2%
View More
Highlights
- Market Capitalization 184.84 million
- Book Value Per Share $0.36
View More
Share Statistics
- Shares Outstanding 330.29 million
- Shares Float 291.83 million
- % Held by Insiders 338%
- % Held by Institutions 3.57%
View More
Technicals
- Beta 1.46
- 52 Week High $1.07
- 52 Week Low $0.2
- 50 Day Moving Average 0.62
- 200 Day Moving Average 0.47
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Aleafia Health Inc (ALEAF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Aleafia Health Inc (ALEAF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-06-30 | 2020-09-30 | $N/A | -$0.05 | $0.00 | |
| 2020-03-31 | 2020-06-30 | $14.6 million | -$0.01 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $6.03 million | -$0.02 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $4.96 million | -$0.03 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $3.84 million | $0.01 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $1.52 million | -$0.03 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $357698 | -$0.09 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $1.64 million | -$0.06 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $181146.67 | -$0.02 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $124374 | -$0.01 | $0.00 | |
| 2017-12-31 | 2018-03-31 | -$0.02 | $0.00 | ||
| 2017-09-30 | 2017-12-31 | $400 | -$0.02 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $N/A | -$0.01 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $N/A | $-0.00 | $0.00 | |
| 2016-12-31 | 2017-03-31 | -$1.73 | $0.00 |
Aleafia Health Inc (ALEAF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | -5.66 million | -6.14 million | 1.86 million |
| Selling General Administrative | N/A | N/A | 6.56 million | 1.64 million | 5.62 million |
| Gross Profit | N/A | N/A | 5.86 million | 5.54 million | 12.4 million |
| Ebit | N/A | N/A | -839000 | -2.23 million | 6.78 million |
| Operating Income | N/A | N/A | -2.72 million | 1.7 million | 3.94 million |
| Income Tax Expense | -4.39 million | -1.5 million | 500000 | 3.62 million | N/A |
| Total Revenue | N/A | N/A | 14.6 million | 6.03 million | 4.96 million |
| Cost of Revenue | N/A | N/A | 8.74 million | 486008 | -7.44 million |
| Total Other Income Expense Net | N/A | N/A | -292000 | -6.18 million | 326869 |
| Net Income From Continuing Operations | N/A | N/A | -6.16 million | -9.76 million | 1.86 million |
| Net Income Applicable to Common Shares | -19.76 million | -4.02 million | -6.16 million | -9.76 million | 1.86 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -4.27 million | N/A | -7.9 million | -4.82 million | 7.87 million |
| Change to Liabilities | 8.8 million | 5.8 million | -9.43 million | 9.32 million | 3.48 million |
| Total Cash Flow from Investing Activities | -4.27 million | -5.73 million | -7.9 million | -4.82 million | 7.87 million |
| Net Borrowings | -177000 | -131000 | -115000 | -2.07 million | -2.37 million |
| Total Cash Flow from Financial Activities | -133000 | N/A | -115000 | -4 million | -6.34 million |
| Change to Operating Activities | -4.39 million | 32.59 million | -1.18 million | 16.07 million | -2.3 million |
| Change in Cash | -10.84 million | N/A | -7.87 million | -10.34 million | -6.39 million |
| Total Cash from Operating Activities | -6.44 million | 4.88 million | 146000 | -1.51 million | -7.93 million |
| Depreciation | 3.27 million | N/A | 2.17 million | 2.36 million | 2.68 million |
| Other Cash Flow from Investing Activities | -80000 | 259000 | 43000 | 408133 | -1.03 million |
| Change to Inventory | 27.03 million | N/A | 5.02 million | -26.07 million | -3.56 million |
| Change to Account Receivables | 8.68 million | N/A | -2.38 million | 2.34 million | -2.19 million |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | -2.95 million | -2.95 million |
| Change to Net Income | -27.48 million | -3.57 million | 8.73 million | 9.44 million | -8.28 million |
| Capital Expenditures | 4.09 million | N/A | 7.94 million | 2.81 million | 6.01 million |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 83.96 million | N/A | 70.13 million | 77.84 million | 64.3 million |
| Total Stockholder Equity | 370.78 million | N/A | 379.32 million | 384.52 million | 393.03 million |
| Other Current Liabilities | 55000 | N/A | N/A | 101000 | 148480 |
| Total Assets | 454.74 million | N/A | 449.45 million | 462.36 million | 457.34 million |
| Common Stock | 384.76 million | 384.76 million | 371.74 million | 371.74 million | 371.31 million |
| Other Current Assets | 17.37 million | N/A | 425000 | 971000 | 13.66 million |
| Retained Earnings | -97.72 million | -77.96 million | -73.99 million | -67.83 million | -58.08 million |
| Other Liabilities | N/A | 2.99 million | 4.2 million | 5.39 million | 2.36 million |
| Other Assets | 814000 | 733000 | 992000 | 4.65 million | 25.9 million |
| Cash | 34.56 million | N/A | 33.38 million | 41.25 million | 51.59 million |
| Total Current Liabilities | 49.56 million | N/A | 34.93 million | 20.74 million | 10.87 million |
| Other Stockholder Equity | N/A | 44.63 million | 44.7 million | 44.7 million | 44.7 million |
| Property, Plant & Equipment | 80.67 million | 78.06 million | 72.29 million | 65.41 million | 63.33 million |
| Total Current Assets | 101 million | N/A | 102.62 million | 117.64 million | 94.28 million |
| Long Term Investments | 5.52 million | N/A | 4.62 million | 4.62 million | 4.62 million |
| Net Tangible Assets | 104.05 million | 121.97 million | 110.39 million | 114.47 million | 123.83 million |
| Short Term Investments | 8.78 million | N/A | 1.6 million | 1.45 million | 5.59 million |
| Long Term Debt | 31.74 million | N/A | 30.42 million | 51.01 million | 50.24 million |
| Inventory | 36.69 million | N/A | 29.09 million | 34.12 million | 7.82 million |
| Accounts Payable | 25.35 million | N/A | 10.72 million | 19.53 million | 9.73 million |
Aleafia Health Inc (ALEAF) Chart:
Aleafia Health Inc (ALEAF) News:
Below you will find a list of latest news for Aleafia Health Inc (ALEAF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Aleafia Health Inc (ALEAF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Aleafia Health Inc (ALEAF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2019-09-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319005837/0001171843-19-005837-index.htm |
| 2018-12-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299318005107/0001062993-18-005107-index.htm |
| 2019-01-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319000038/0001062993-19-000038-index.htm |
| 2019-01-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319000150/0001062993-19-000150-index.htm |
| 2019-01-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319000182/0001062993-19-000182-index.htm |
| 2019-01-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319000317/0001062993-19-000317-index.htm |
| 2019-01-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319000319/0001062993-19-000319-index.htm |
| 2019-01-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319000374/0001062993-19-000374-index.htm |
| 2019-02-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319000446/0001062993-19-000446-index.htm |
| 2019-02-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319000448/0001062993-19-000448-index.htm |
| 2019-02-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319000965/0001062993-19-000965-index.htm |
| 2019-02-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319001025/0001062993-19-001025-index.htm |
| 2019-03-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319001195/0001062993-19-001195-index.htm |
| 2019-03-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319001288/0001062993-19-001288-index.htm |
| 2019-03-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319001416/0001062993-19-001416-index.htm |
| 2019-04-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319001566/0001062993-19-001566-index.htm |
| 2019-04-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319001648/0001062993-19-001648-index.htm |
| 2019-04-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000106299319001816/0001062993-19-001816-index.htm |
| 2019-07-02 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1754664/000106299319002771/0001062993-19-002771-index.htm |
| 2019-04-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319002324/0001171843-19-002324-index.htm |
| 2019-04-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319002356/0001171843-19-002356-index.htm |
| 2019-04-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319002365/0001171843-19-002365-index.htm |
| 2019-04-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319002402/0001171843-19-002402-index.htm |
| 2019-04-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319002432/0001171843-19-002432-index.htm |
| 2019-04-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319002525/0001171843-19-002525-index.htm |
| 2019-04-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319002552/0001171843-19-002552-index.htm |
| 2019-04-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319002698/0001171843-19-002698-index.htm |
| 2019-05-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319002970/0001171843-19-002970-index.htm |
| 2019-05-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319003147/0001171843-19-003147-index.htm |
| 2019-05-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319003185/0001171843-19-003185-index.htm |
| 2019-05-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319003284/0001171843-19-003284-index.htm |
| 2019-06-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319003913/0001171843-19-003913-index.htm |
| 2019-06-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319003973/0001171843-19-003973-index.htm |
| 2019-07-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319004289/0001171843-19-004289-index.htm |
| 2019-07-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319004349/0001171843-19-004349-index.htm |
| 2019-07-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319004563/0001171843-19-004563-index.htm |
| 2019-07-24 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319004752/0001171843-19-004752-index.htm |
| 2019-08-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319005076/0001171843-19-005076-index.htm |
| 2019-08-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319005307/0001171843-19-005307-index.htm |
| 2019-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319005489/0001171843-19-005489-index.htm |
| 2019-09-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1754664/000117184319005837/0001171843-19-005837-index.htm |